Market Segmentation Tab
Connected Healthcare Type Outlook (USD Billion, 2019-2030)
Connected Healthcare Application Outlook (USD Billion, 2019-2030)
Connected Healthcare Regional Outlook (USD Billion, 2019-2030)
1 Report Prologue
2 Introduction
2.1 Scope Of Study 15
2.2 Research Objective 15
2.3 Assumptions & Limitations 15
2.3.1 Assumptions 15
2.3.2 Limitations 16
2.4 Market Structure 16
3 Research Methodology
3.1 Research Process 17
3.2 Primary Research 18
3.3 Secondary Research 18
4 Market Dynamics
4.1 Introduction 19
4.2 Drivers 19
4.2.1 Connected Healthcare Applications Have Increased The Involvement Of Patient Population 19
4.2.2 Increasing Use Of Smartphones And Wearable Devices Into Healthcare Has Led To The Growth Of The Market 20
4.2.3 Cost Effectiveness And Patient’s Convenience Is Expected To Drive The Connected Healthcare Market 20
4.2.4 Continuous Increase In Lifestyle Disease Has Led To The Development Of Personalized Healthcare Solutions 20
4.3 Restraints 21
4.3.1 Increasing Privacy And Cybercrimes Restraint The Growth Of Connected Healthcare Market 21
4.3.2 Lack Of Awareness About The Possible Applications Of Connected Healthcare 22
4.3.3 Reluctance To Share Information Regarding The Health Has Limited The Growth Of The Market 22
4.4 Opportunities 22
4.4.1 Growing Partnership Between The Companies Has Become The Entrance Gateway For New Firms 22
4.4.2 Introduction Of Connected Healthcare In Developing Economies Will Boost The Growth Of The Connected Healthcare Market 22
4.5 Challenges 23
4.5.1 Low Rate Of Literacy And Language Barriers In Low– And Middle–Income Countries (LMICs) Is A Big Challenge For The Connected Healthcare Solutions 23
4.5.2 Potential Risk Of Hardware Or Software Failure Will Bar The Growth Of The Market 23
4.5.3 Stringent Regulations And Standards Is Likely To Restrain The Growth Of The Market 24
5 Market Factor Analysis
5.1 Connected Healthcare Device: Porter’s Five Force Analysis 25
5.1.1 Bargaining Power Of Buyer 26
5.1.2 Bargaining Power Of Supplier 27
5.1.3 Threat From Substitute 27
5.1.4 Threat From A New Entrant 27
5.1.5 Intensity Of Competitive Rivalry 27
5.2 Value Chain Analysis 28
5.2.1 Device Manufacturers 29
5.2.2 App Developers 30
5.2.3 Network Providers/ Mobile Operators 30
5.2.4 Healthcare Providers And Pharmaceuticals 30
5.2.5 Patients 30
6 Connected Healthcare Market, By Types
6.1 Introduction 32
6.2 M–Health Services 32
6.2.1 Mobile Health Apps And Content Solution 34
6.2.1.1 Software 34
6.2.1.2 Big Data 34
6.2.2 Network And Services/ Mobile Operators 35
6.2.3 Healthcare Providers And Pharmaceuticals 35
6.2.3.1 Healthcare Providers 35
6.2.3.2 Pharmaceuticals 36
6.3 M–Health Devices 36
6.3.1 Medical Devices 38
6.3.1.1 SMBG 39
6.3.1.2 Blood Pressure Monitor 39
6.3.1.3 Cardiac Monitors 40
6.3.1.4 Pulse Oximeter 40
6.3.1.5 Other Medical Devices 40
6.3.2 Wearable Devices 41
6.3.2.1 Hand Worn Products 43
6.3.2.1.1 Smart Watch 43
6.3.2.1.2 Wrist Wear 43
6.3.2.2 Head Worn Products 43
6.3.2.2.1 AR/VR HMD/HUD 43
6.3.2.2.2 Others 43
6.3.2.3 Body Worn Products 44
6.3.2.3.1 Smart Textile 44
6.3.2.3.2 Wearable Patch 44
6.3.2.3.3 Others 45
6.3.3 Connected Drug Delivery Systems 45
6.3.3.1 Auto–Injectors 46
6.3.3.2 Inhalers 47
6.4 E–Prescription 48
7 Connected Healthcare Market, By Applications
7.1 Introduction 51
7.2 Monitoring Applications 53
7.3 Diagnosis & Treatment 54
7.4 Education & Awareness 54
7.5 Healthcare Management 55
7.6 Wellness & Prevention 57
7.7 Other Applications 58
8 Connected Healthcare Market, By Regions
8.1 Introduction 60
8.2 North America 62
8.2.1 Introduction 62
8.2.2 US …………………………………………………………………………………………………64
8.2.3 Canada 66
8.3 Europe 68
8.3.1 Introduction 68
8.3.2 Germany 71
8.3.3 France 72
8.3.4 UK 73
8.3.5 Italy 74
8.3.6 Spain 75
8.4 Asia–Pacific 76
8.4.1 Introduction 76
8.4.2 Japan 80
8.4.3 China 82
8.4.4 India 83
8.4.5 Australia 85
8.4.6 South Korea 86
8.5 Middle East & Africa 87
8.5.1 Introduction 87
8.5.2 Africa 88
8.5.3 Middle East 88
9 Competitive Landscape
9.1 Introduction 91
9.1.1 Partnerships, Agreements And Collaborations 92
9.1.2 Product Development And Launch 94
9.1.3 Approvals 97
9.1.4 Acquisitions 98
9.1.5 Award & Recognition 99
9.1.6 Others 99
10 Company Profile
10.1 Agamatrix, Inc. 101
10.1.1 Company Overview 101
10.1.2 Product/Business Segment Overview 101
10.1.3 Financial Overview 101
10.1.4 Key Development 101
10.1.5 SWOT Analysis 102
10.2 AirStrip Technologies 103
10.2.1 Company Overview 103
10.2.2 Product/Business Segment Overview 103
10.2.3 Financial Overview 103
10.2.4 Key Development 103
10.2.5 SWOT Analysis 104
10.3 AliveCor Inc. 105
10.3.1 Company Overview 105
10.3.2 Product/Business Segment Overview 105
10.3.3 Financial Overview 105
10.3.4 Key Development 105
10.3.5 SWOT Analysis 106
10.4 Allscripts 106
10.4.1 Company Overview 106
10.4.2 Product/Business Segment Overview 107
10.4.3 Financial Overview 107
10.4.4 Key Development 109
10.4.5 SWOT Analysis 109
10.5 Apple Inc. 110
10.5.1 Company Overview 110
10.5.2 Product/Business Segment Overview 110
10.5.3 Financial Overview 110
10.5.4 SWOT Analysis 112
10.6 Athenahealth, Inc. 113
10.6.1 Company Overview 113
10.6.2 Product/Business Segment Overview 113
10.6.3 Financial Overview 113
10.6.4 Key Development 114
10.6.5 SWOT Analysis 114
10.7 Boston Scientific Corporation 115
10.7.1 Company Overview 115
10.7.2 Product/Business Segment Overview 115
10.7.3 Financial Overview 115
10.7.4 Key Development 116
10.7.5 SWOT Analysis 117
10.8 Cerner 118
10.8.1 Company Overview 118
10.8.2 Product/Business Segment Overview 118
10.8.3 Financial Overview 118
10.8.4 Key Development 119
10.8.5 SWOT Analysis 120
10.9 GE Healthcare 121
10.9.1 Company Overview 121
10.9.2 Product/Business Segment Overview 121
10.9.3 Financial Overview 121
10.9.4 Key Development 123
10.9.5 SWOT Analysis 123
10.10 Honeywell Life Care Solutions 124
10.10.1 Company Overview 124
10.10.2 Product/Business Segment Overview 124
10.10.3 Financial Overview 124
10.10.4 Key Development 126
10.10.5 SWOT Analysis 126
10.11 Medtronics 127
10.11.1 Company Overview 127
10.11.2 Product/Business Segment Overview 127
10.11.3 Financial Overview 127
10.11.4 Key Development 128
10.11.5 SWOT Analysis 129
10.12 Microsoft 130
10.12.1 Company Overview 130
10.12.2 Product/Business Segment Overview 130
10.12.3 Financial Overview 130
10.12.4 SWOT Analysis 132
10.13 Persistent Systems 133
10.13.1 Company Overview 133
10.13.2 Product/Business Segment Overview 133
10.13.3 Financial Overview 133
10.13.4 Key Development 134
10.13.5 SWOT Analysis 135
10.14 Koninklijke Philips NV 136
10.14.1 Company Overview 136
10.14.2 Product/Business Segment Overview 136
10.14.3 Financial Overview 136
10.14.4 Key Development 137
10.14.5 SWOT Analysis 138
10.15 Qualcomm 139
10.15.1 Company Overview 139
10.15.2 Product/Business Segment Overview 139
10.15.3 Financial Overview 139
10.15.4 Key Development 140
10.15.5 SWOT Analysis 141
10.16 Sanofi 142
10.16.1 Company Overview 142
10.16.2 Product/Business Segment Overview 142
10.16.3 Financial Overview 142
10.16.4 Key Development 143
10.16.5 SWOT Analysis 145
10.17 Vivify Health, Inc. 146
10.17.1 Company Overview 146
10.17.2 Product/Business Segment Overview 146
10.17.3 Financial Overview 146
10.17.4 SWOT Analysis 147
11 Appendix
12 List Of Tables
TABLE 1 GLOBAL CONNECTED HEALTHCARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 32
TABLE 2 M-HEALTH SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 33
TABLE 3 M-HEALTH DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 37
TABLE 4 MEDICAL DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 38
TABLE 5 WEARABLE DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 42
TABLE 6 CONNECTED DRUG DELIVERY SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION) 46
TABLE 7 E-PRESCRIPTION MARKET, BY REGION, 2020–2027 (USD MILLION) 49
TABLE 8 GLOBAL CONNECTED HEALTHCARE MARKET VALUE, BY APPLICATION, 2020–2027 (USDMILLION) 52
TABLE 9 MONITORING APPLICATIONS MARKET, BY REGION, 2020–2027 (USDMILLION) 53
TABLE 10 DIAGNOSIS & TREATMENTS MARKET, BY REGION, 2020–2027 (USDMILLION) 54
TABLE 11 EDUCATION & AWARENESSS MARKET, BY REGION, 2020–2027 (USD MILLION) 55
TABLE 12 HEALTHCARE MANAGEMENTS MARKET, BY REGION, 2020–2027 (USD MILLION) 55
TABLE 13 WELLNESS & PREVENTIONS MARKET, BY REGION, 2020–2027 (USDMILLION) 57
TABLE 14 OTHER APPLICATIONS: GLOBAL CONNECTED HEALTHCARE MARKET VALUE, BY GEOGRAPHY, 2014–2027 (USDMILLION) 58
TABLE 15 GLOBAL CONNECTED HEALTHCARE MARKET, BY REGION, 2020–2027(USD MILLION) 61
TABLE 16 NORTH AMERICA CONNECTED HEALTHCARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 62
TABLE 17 NORTH AMERICA CONNECTED HEALTHCARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 63
TABLE 18 NORTH AMERICA CONNECTED HEALTHCARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 64
TABLE 19 NORTH AMERICA CONNECTED HEALTHCARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 64
TABLE 20 US CONNECTED HEALTHCARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 65
TABLE 21 US CONNECTED HEALTHCARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 65
TABLE 22 CANADA CONNECTED HEALTHCARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 67
TABLE 23 CANADA CONNECTED HEALTHCARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 67
TABLE 24 EUROPE CONNECTED HEALTHCARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 69
TABLE 25 EUROPE CONNECTED HEALTHCARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 69
TABLE 26 EUROPE CONNECTED HEALTHCARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 70
TABLE 27 GERMANY CONNECTED HEALTHCARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 71
TABLE 28 GERMANY CONNECTED HEALTHCARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 71
TABLE 29 FRANCE CONNECTED HEALTHCARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 72
TABLE 30 FRANCE CONNECTED HEALTHCARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 72
TABLE 31 UK CONNECTED HEALTHCARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 73
TABLE 32 UK CONNECTED HEALTHCARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 74
TABLE 33 ITALY CONNECTED HEALTHCARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 74
TABLE 34 ITALY CONNECTED HEALTHCARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 75
TABLE 35 SPAIN CONNECTED HEALTHCARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 75
TABLE 36 SPAIN CONNECTED HEALTHCARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 76
TABLE 37 ASIA-PACIFIC CONNECTED HEALTHCARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 78
TABLE 38 ASIA-PACIFIC CONNECTED HEALTHCARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 79
TABLE 39 ASIA-PACIFIC CONNECTED HEALTHCARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 80
TABLE 40 JAPAN CONNECTED HEALTHCARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 81
TABLE 41 JAPAN CONNECTED HEALTHCARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 81
TABLE 42 CHINA CONNECTED HEALTHCARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 82
TABLE 43 CHINA CONNECTED HEALTHCARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 83
TABLE 44 INDIA CONNECTED HEALTHCARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 84
TABLE 45 INDIA CONNECTED HEALTHCARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 84
TABLE 46 AUSTRALIA CONNECTED HEALTHCARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 85
TABLE 47 AUSTRALIA CONNECTED HEALTHCARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 86
TABLE 48 SOUTH KOREA CONNECTED HEALTHCARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 86
TABLE 49 SOUTH KOREA CONNECTED HEALTHCARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 87
TABLE 50 MIDDLE EAST & AFRICA CONNECTED HEALTHCARE MARKET, BY REGION, 2020–2027 (USD MILLION) 88
TABLE 51 MIDDLE EAST & AFRICA CONNECTED HEALTHCARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 89
TABLE 52 MIDDLE EAST & AFRICA CONNECTED HEALTHCARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 90
TABLE 53 CONNECTED HEALTHCARE: PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 92
TABLE 54 CONNECTED HEALTHCARE: PRODUCT DEVELOPMENT AND LAUNCH 96
TABLE 55 CONNECTED HEALTHCARE: APPROVALS 97
TABLE 56 CONNECTED HEALTHCARE: ACQUISITIONS 99
TABLE 57 CONNECTED HEALTHCARE: AWARD & RECOGNITION 99
TABLE 58 CONNECTED HEALTHCARE: OTHERS 100
TABLE 59 AGAMATRIX, INC.: KEY DEVELOPMENT 101
TABLE 60 AIRSTRIP TECHNOLOGIES: KEY DEVELOPMENT 103
TABLE 61 ALIVECOR INC.: KEY DEVELOPMENT 105
TABLE 62 ALLSCRIPTS: KEY DEVELOPMENT 109
TABLE 63 ATHENAHEALTH, INC.: KEY DEVELOPMENT 114
TABLE 64 BOSTON SCIENTIFIC CORPORATION: KEY DEVELOPMENT 116
TABLE 65 CERNER: KEY DEVELOPMENT 119
TABLE 66 GE HEALTHCARE: KEY DEVELOPMENT 123
TABLE 67 HONEYWELL LIFE CARE SOLUTIONS: KEY DEVELOPMENT 126
TABLE 68 MEDTRONICS: KEY DEVELOPMENT 128
TABLE 69 PERSISTENT SYSTEMS: KEY DEVELOPMENT 134
TABLE 70 KONINKLIJKE PHILIPS NV: KEY DEVELOPMENT 137
TABLE 71 QUALCOMM: KEY DEVELOPMENT 140
TABLE 72 SANOFI: KEY DEVELOPMENT 143
13 List Of Figures
FIGURE 1 GLOBAL CONNECTED HEALTHCARE: MARKET STRUCTURE 16
FIGURE 2 RESEARCH PROCESS OF MRFR 17
FIGURE 3 GLOBAL CONNECTED HEALTHCARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES 19
FIGURE 4 GLOBAL CONNECTED HEALTHCARE MARKET: PORTER FIVE FORCES ANALYSIS 26
FIGURE 5 GLOBAL CONNECTED HEALTHCARE MARKET: VALUE CHAIN 29
FIGURE 6 GLOBAL CONNECTED HEALTHCARE MARKET, BY TYPE, 2020 (%) 32
FIGURE 7 M-HEALTH SERVICES MARKET, BY REGION, 2020 & 2027 (USD MILLION) 33
FIGURE 8 TYPES OF CONNECTED HEALTHCARE SERVICES 33
FIGURE 9 M-HEALTH DEVICES MARKET, BY REGION, 2020 & 2027 (USD MILLION) 36
FIGURE 10 TYPE OF CONNECTED HEALTHCARE DEVICES 38
FIGURE 11 TYPES OF WEARABLE DEVICES 42
FIGURE 12 E-PRESCRIPTION MARKET, BY REGION, 2020 & 2027 (USD MILLION) 48
FIGURE 13 TYPES OF CONNECTED HEALTHCARE APPLICATION 51
FIGURE 14 GLOBAL CONNECTED HEALTHCARE MARKET, BY APPLICATION, 2020 & 2027 (USD MILLION) 52
FIGURE 15 GLOBAL CONNECTED HEALTHCARE MARKET SHARE, BY REGIONS 60
FIGURE 16 GLOBAL CONNECTED HEALTHCARE MARKET, BY REGION, 2020 & 2027 (USD MILLION) 61
FIGURE 17 NORTH AMERICA CONNECTED HEALTHCARE MARKET, BY COUNTRY, 2020 (%) 62
FIGURE 18 NORTH AMERICA CONNECTED HEALTHCARE MARKET, BY TYPE, 2020 & 2027 (USD MILLION) 63
FIGURE 19 EUROPE CONNECTED HEALTHCARE MARKET, BY COUNTRY, 2020 (%) 68
FIGURE 20 EUROPE CONNECTED HEALTHCARE MARKET, BY TYPE, 2020 & 2027 (USD MILLION) 69
FIGURE 21 EUROPE CONNECTED HEALTHCARE MARKET, BY APPLICATION, 2020 & 2027 (USD MILLION) 70
FIGURE 22 ASIA-PACIFIC CONNECTED HEALTHCARE MARKET, BY COUNTRY, 2020 (%) 77
FIGURE 23 ASIA-PACIFIC CONNECTED HEALTHCARE MARKET, BY TYPE, 2020 & 2027 (USD MILLION) 78
FIGURE 24 ASIA-PACIFIC CONNECTED HEALTHCARE MARKET, BY APPLICATION, 2020 & 2027 (USD MILLION) 79
FIGURE 25 MIDDLE EAST & AFRICA CONNECTED HEALTHCARE MARKET, BY COUNTRY, 2020 (%) 88
FIGURE 26 MIDDLE EAST & AFRICA CONNECTED HEALTHCARE MARKET, BY TYPE, 2020 & 2027 (USD MILLION) 89
FIGURE 27 MIDDLE EAST & AFRICA CONNECTED HEALTHCARE MARKET, BY APPLICATION, 2020 & 2027 (USD MILLION) 90
FIGURE 28 COMPETITIVE ANALYSIS 92
FIGURE 1 AGAMATRIX, INC.: SWOT ANALYSIS 102
FIGURE 2 AIRSTRIP TECHNOLOGIES: SWOT ANALYSIS 104
FIGURE 3 ALIVECOR INC.: SWOT ANALYSIS 106
FIGURE 4 ALLSCRIPTS: RECENT FINANCIAL 107
FIGURE 5 ALLSCRIPTS: OPERATING SEGMENTS 108
FIGURE 6 ALLSCRIPTS: GEOGRAPHIC REVENUE MIX 108
FIGURE 7 ALLSCRIPTS: SWOT ANALYSIS 109
FIGURE 8 APPLE INC.: RECENT FINANCIAL 110
FIGURE 9 APPLE INC.: OPERATING SEGMENTS 111
FIGURE 10 APPLE INC.: GEOGRAPHIC REVENUE MIX 111
FIGURE 11 APPLE INC.: SWOT ANALYSIS 112
FIGURE 12 ATHENAHEALTH, INC.: RECENT FINANCIAL 113
FIGURE 13 ATHENAHEALTH, INC.: SWOT ANALYSIS 114
FIGURE 14 BOSTON SCIENTIFIC CORPORATION: RECENT FINANCIAL 115
FIGURE 15 BOSTON SCIENTIFIC CORPORATION: RECENT FINANCIAL 116
FIGURE 16 BOSTON SCIENTIFIC CORPORATION: SWOT ANALYSIS 117
FIGURE 17 CERNER: RECENT FINANCIAL 118
FIGURE 18 CERNER: GEOGRAPHICAL MIX 119
FIGURE 19 CERNER: SWOT ANALYSIS 120
FIGURE 20 GE HEALTHCARE: RECENT FINANCIAL 121
FIGURE 21 GE HEALTHCARE: OPERATING SEGMENTS 122
FIGURE 22 GE HEALTHCARE: GEOGRAPHICAL MIX 122
FIGURE 23 GE HEALTHCARE: SWOT ANALYSIS 123
FIGURE 24 HONEYWELL LIFE CARE SOLUTIONS: RECENT FINANCIAL 124
FIGURE 25 HONEYWELL LIFE CARE SOLUTIONS: OPERATING SEGMENTS 125
FIGURE 26 HONEYWELL LIFE CARE SOLUTIONS: GEOGRAPHICAL MIX 125
FIGURE 27 HONEYWELL LIFE CARE SOLUTIONS: SWOT ANALYSIS 126
FIGURE 28 MEDTRONICS: RECENT FINANCIAL 127
FIGURE 29 MEDTRONICS: OPERATING SEGMENTS 128
FIGURE 30 MEDTRONICS: GEOGRAPHICAL MIX 128
FIGURE 31 MEDTRONICS: SWOT ANALYSIS 129
FIGURE 32 MICROSOFT: RECENT FINANCIAL 130
FIGURE 33 MICROSOFT: OPERATING SEGMENTS 131
FIGURE 34 MICROSOFT: GEOGRAPHICAL MIX 131
FIGURE 35 MICROSOFT: SWOT ANALYSIS 132
FIGURE 36 PERSISTENT SYSTEMS: RECENT FINANCIAL 133
FIGURE 37 PERSISTENT SYSTEMS: GEOGRAPHICAL MIX 134
FIGURE 38 PERSISTENT SYSTEMS: SWOT ANALYSIS 135
FIGURE 39 KONINKLIJKE PHILIPS NV: RECENT FINANCIAL 136
FIGURE 40 KONINKLIJKE PHILIPS NV: OPERATING SEGMENTS 137
FIGURE 41 KONINKLIJKE PHILIPS NV: GEOGRAPHICAL MIX 137
FIGURE 42 KONINKLIJKE PHILIPS NV: SWOT ANALYSIS 138
FIGURE 43 QUALCOMM: RECENT FINANCIAL 139
FIGURE 44 QUALCOMM: GEOGRAPHICAL MIX 140
FIGURE 45 QUALCOMM: SWOT ANALYSIS 141
FIGURE 46 SANOFI: RECENT FINANCIAL 142
FIGURE 47 SANOFI: OPERATING SEGMENTS 143
FIGURE 48 SANOFI: GEOGRAPHICAL MIX 143
FIGURE 49 SANOFI: SWOT ANALYSIS 145
FIGURE 50 VIVIFY HEALTH, INC.: SWOT ANALYSIS 147
Research Analyst Level I He is an extremely curious individual currently working in healthcare and medical devices domain. kinjoll is comfortably versed in data centric research backed by healthcare educational background. he leverages extensive data mining and analytics tools such as primary and secondary research, statistical analysis, machine learning, data modelling. his key role also involves technical sales support, client interaction and project management within the healthcare team. lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
